COOPMED: what changed
COOPMED
Largest movements
- Cash -€1.2m
down €1.2m (-78.1%), from €1.5m to €335,630
mainly Current portion of long-term debt (-€1.6m) and Provisions (-€178,000)
- Receivables within one year -€757,498
down €757,498 (-94.0%), from €805,638 to €48,140
of which Other amounts receivable: -€758,056
- Current portion of long-term debt -€1.6m
down €1.6m (-58.2%), from €2.8m to €1.2m
- Provisions -€178,000
down €178,000 (-69.6%), from €255,900 to €77,900
- Accrued charges and deferred income -€163,507
down €163,507 (-84.2%), from €194,215 to €30,708
- Profit (loss) carried forward -€24,488
down €24,488 (-0.5%), from -€5.3m to -€5.3m
- Gross operating margin -€2.3m
down €2.3m (-97.8%), from €2.3m to €50,721
- Financial income +€420,744
up €420,744 (+125%), from €337,463 to €758,207
of which Non-recurring financial income: +€676,700
- Financial charges +€371,948
up €371,948 (+106%), from €352,377 to €724,325
- Other operating charges +€92,286
up €92,286 (+1,119%), from €8,245 to €100,531
Change in the result, 2024 to 2025
For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.
Derived cash bridge
The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €2,351,210 | €385,413 | -€2.0m | -83.6% |
| Formation expenses | 20 | €3,438 | - | -€3,438 | |
| Current assets | 29/58 | €2,347,772 | €385,413 | -€2.0m | -83.6% |
| Amounts receivable within one year | 40/41 | €805,638 | €48,140 | -€757,498 | -94.0% |
| Trade receivables | 40 | €1,172 | €1,730 | +€558 | +47.6% |
| Other amounts receivable | 41 | €804,466 | €46,410 | -€758,056 | -94.2% |
| Cash at bank and in hand | 54/58 | €1,532,841 | €335,630 | -€1.2m | -78.1% |
| Deferred charges and accrued income | 490/1 | €9,294 | €1,642 | -€7,651 | -82.3% |
| Total equity and liabilities | 10/49 | €2,351,210 | €385,413 | -€2.0m | -83.6% |
| Equity | 10/15 | -€913,745 | -€938,232 | -€24,488 | -2.7% |
| Contributions | 10/11 | €4,350,000 | €4,350,000 | = | 0.0% |
| Capital | 10 | €4,350,000 | €4,350,000 | = | 0.0% |
| Issued capital | 100 | €4,350,000 | €4,350,000 | = | 0.0% |
| Profit (loss) carried forward | 14 | -€5,263,745 | -€5,288,232 | -€24,488 | -0.5% |
| Provisions and deferred taxes | 16 | €255,900 | €77,900 | -€178,000 | -69.6% |
| Provisions for liabilities and charges | 160/5 | €255,900 | €77,900 | -€178,000 | -69.6% |
| Other liabilities and charges | 164/5 | €255,900 | €77,900 | -€178,000 | -69.6% |
| Amounts payable | 17/49 | €3,009,055 | €1,245,745 | -€1.8m | -58.6% |
| Amounts payable within one year | 42/48 | €2,814,840 | €1,215,038 | -€1.6m | -56.8% |
| Current portion of amounts payable after more than one year | 42 | €2,750,000 | €1,150,000 | -€1.6m | -58.2% |
| Trade debts | 44 | €64,840 | €65,038 | +€197 | +0.3% |
| Suppliers | 440/4 | €64,840 | €65,038 | +€197 | +0.3% |
| Accrued charges and deferred income | 492/3 | €194,215 | €30,708 | -€163,507 | -84.2% |
| Non-recurring operating income | 76A | €2,550,556 | €178,000 | -€2.4m | -93.0% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €11,057 | €3,438 | -€7,619 | -68.9% |
| Other operating charges | 640/8 | €8,245 | €100,531 | +€92,286 | +1,119% |
| Non-recurring operating charges | 66A | €2,733,350 | €5,122 | -€2.7m | -99.8% |
| Gross operating margin | 9900 | €2,329,643 | €50,721 | -€2.3m | -97.8% |
| Operating profit (loss) | 9901 | -€423,009 | -€58,370 | +€364,639 | +86.2% |
| Financial income | 75/76B | €337,463 | €758,207 | +€420,744 | +125% |
| Recurring financial income | 75 | €337,463 | €81,508 | -€255,956 | -75.8% |
| Non-recurring financial income | 76B | - | €676,700 | +€676,700 | |
| Financial charges | 65/66B | €352,377 | €724,325 | +€371,948 | +106% |
| Recurring financial charges | 65 | €352,377 | €724,325 | +€371,948 | +106% |
| Profit (loss) for the period before taxes | 9903 | -€437,923 | -€24,488 | +€413,435 | +94.4% |
| Income taxes | 67/77 | €2,471 | - | -€2,471 | |
| Profit (loss) for the period | 9904 | -€440,394 | -€24,488 | +€415,906 | +94.4% |
| Profit (loss) for the period to be appropriated | 9905 | -€440,394 | -€24,488 | +€415,906 | +94.4% |
Next steps
Calculation and sources
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Green is a favourable move for that line, red an unfavourable one. Prepared on 3 November 2026 via checked.be.